Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;12(5):627-36.
doi: 10.1038/nn.2297. Epub 2009 Mar 29.

A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice

Affiliations

A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice

Smita Saxena et al. Nat Neurosci. 2009 May.

Abstract

The mechanisms underlying disease manifestations in neurodegeneration remain unclear, but their understanding is critical to devising effective therapies. We carry out a longitudinal analysis in vivo of identified motoneurons selectively vulnerable (VUL) or resistant (RES) to motoneuron disease (amyotrophic lateral sclerosis, ALS) and show that subtype-selective endoplasmic reticulum (ER) stress responses influence disease manifestations. VUL motoneurons were selectively prone to ER stress and showed gradually upregulated ER stress markers from birth on in three mouse models of familial ALS (FALS). 25-30 days before the earliest denervations, ubiquitin signals increased in both VUL and RES motoneurons, but an unfolded protein response coupled with microglial activation was initiated selectively in VUL motoneurons. This transition was followed by selective axonal degeneration and spreading stress. The ER stress-protective agent salubrinal attenuated disease manifestations and delayed progression, whereas chronic enhancement of ER stress promoted disease. Thus, whereas all motoneurons are preferentially affected in ALS, ER stress responses in specific motoneuron subtypes influence the progressive manifestations of weakening and paralysis.

PubMed Disclaimer

Comment in

References

    1. Neurodegener Dis. 2007;4(6):431-42 - PubMed
    1. FASEB J. 2008 Jul;22(7):2476-87 - PubMed
    1. Science. 1994 Jun 17;264(5166):1772-5 - PubMed
    1. Neuron. 2004 Jul 8;43(1):5-17 - PubMed
    1. Science. 2006 Jun 2;312(5778):1389-92 - PubMed

Publication types

MeSH terms

LinkOut - more resources